The Science Behind the Drug That May Stop Alzheimer’s Disease in Its Tracks

3 min video | 1 min read

A First of Its Kind, ALZ-801 Aims To Preserve Memories, Save Lives: An Exclusive Interview with Dr. Martin Tolar

8 min video | 1 min read

Unprecedented Reduction in Key Alzheimer’s Biomarker for Patients Treated With ALZ-801

6 min video | 1 min read

Part 1: The Role of APOE Genotyping in Alzheimer’s Disease Risk Stratification

8 min video

Part 2: APOE Genotyping in Clinical Practice: Pros and Cons

8 min video

Learn More About Advances in AD Treatments

3 min read

The Science Behind the Drug That May Stop Alzheimer’s Disease in Its Tracks

Video Shows a Novel Approach to Treating Alzheimer’s Disease

In this video we uncover ALZ-801 (valiltramiprosate), the first potential disease-modifying oral treatment for patients with Alzheimer’s disease, and take a look into its novel mode of action. This groundbreaking drug works by preventing formation of neurotoxic amyloid oligomers.